| 0 (0%) | 04-15 11:38 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 19.85 |
1-year : | 23.19 |
| Resists | First : | 17 |
Second : | 19.85 |
| Pivot price | 13.38 |
|||
| Supports | First : | 13.66 |
Second : | 11.6 |
| MAs | MA(5) : | 13.22 |
MA(20) : | 13.86 |
| MA(100) : | 15.71 |
MA(250) : | 24.24 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 42.7 |
D(3) : | 31.2 |
| RSI | RSI(14): 53.3 |
|||
| 52-week | High : | 69.97 | Low : | 11.6 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ TNXP ] has closed below upper band by 17.6%. Bollinger Bands are 30.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 13.91 - 13.98 | 13.98 - 14.04 |
| Low: | 12.77 - 12.85 | 12.85 - 12.91 |
| Close: | 13.23 - 13.35 | 13.35 - 13.46 |
Wed, 15 Apr 2026
Tonix Pharmaceuticals (TNXP) Reports Positive Findings on TNX-10 - GuruFocus
Wed, 15 Apr 2026
20-day study maps how Tonix’s fibromyalgia drug acts overnight - Stock Titan
Sun, 12 Apr 2026
TNXP stock dives for four straight sessions — retail eyes drug pipeline payoff - MSN
Sat, 11 Apr 2026
TNXP Options Volatility — NASDAQ:TNXP - TradingView — Track All Markets
Sat, 11 Apr 2026
TNXP Options Chain — NASDAQ:TNXP - TradingView — Track All Markets
Sun, 05 Apr 2026
Liquidity Mapping Around (TNXP) Price Events - Stock Traders Daily
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 13 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 28.3 (%) |
| Shares Short | 2,470 (K) |
| Shares Short P.Month | 2,360 (K) |
| EPS | -14.57 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 19.17 |
| Profit Margin | 0 % |
| Operating Margin | -895.9 % |
| Return on Assets (ttm) | -35.8 % |
| Return on Equity (ttm) | -64.5 % |
| Qtrly Rev. Growth | 108.8 % |
| Gross Profit (p.s.) | 0.48 |
| Sales Per Share | 0.97 |
| EBITDA (p.s.) | -9.24 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -100 (M) |
| Levered Free Cash Flow | -59 (M) |
| PE Ratio | -0.99 |
| PEG Ratio | 0 |
| Price to Book value | 0.74 |
| Price to Sales | 14.63 |
| Price to Cash Flow | -1.93 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|